Lurasidone (Latuda) Gets FDA Nod for Bipolar Depression in Kids Lurasidone (Latuda) Gets FDA Nod for Bipolar Depression in Kids

Lurasidone is now indicated for the treatment of major depressive episodes associated with bipolar I disorder in children and adolescents aged 10 to 17 years.FDA Approvals

Source: Medscape Medical News Headlines - March 7, 2018 Category: Consumer Health News Tags: Psychiatry News Alert Source Type: news